Clinical trial
Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors…
NCT00089960 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00089960 |
|---|---|
| Title | Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) |
| Official title | An Open Label Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) Who Developed Progressive Disease or Relapsed While on Imatinib Mesylate |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Cancer |
| Intervention type | Drug |
| Interventions | AMG 706 |
| Enrollment | 138 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2008 |
| First posted | Aug 20, 2004 |
| Last update posted | Apr 29, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: